Labcorp (LH) director Victor Bulto Carulla files Form 3 with no securities owned

Rhea-AI Filing Summary

Labcorp Holdings Inc. (LH) disclosed a new Form 3 for director Victor Bulto Carulla, indicating his status as a board member and initial ownership position. The filing states that no securities are beneficially owned at this time, meaning he currently reports no direct or indirect holdings of Labcorp stock or derivative securities.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bulto Carulla Victor

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/01/2025

3. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Victor Bulto Carulla	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Labcorp (LH) report in this Form 3 filing?

Labcorp reports that director Victor Bulto Carulla has filed an initial ownership statement on Form 3, indicating his relationship to the company and current holdings status.

What is the relationship of the reporting person to Labcorp (LH)?

The reporting person, Victor Bulto Carulla, is identified as a Director of Labcorp Holdings Inc.

Does the Labcorp (LH) director report any stock ownership in this Form 3?

The filing states that no securities are beneficially owned, so the director reports no direct or indirect ownership of Labcorp shares or derivative securities in this form.

Is this Labcorp (LH) Form 3 filed by one or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, referring to director Victor Bulto Carulla.

Who signed the Labcorp (LH) Form 3 on behalf of the reporting person?

The Form 3 is signed by /s/ Sandra D. van der Vaart as Attorney-in-Fact for Victor Bulto Carulla, referencing an Exhibit 24 Power of Attorney.

Does this Labcorp (LH) Form 3 include any derivative securities?

The derivative securities table is included in the format, but the remarks clarify that no securities are beneficially owned, so there are no derivative holdings reported.